Bortezomib-containing multimodality treatment for antibody-mediated rejection with anti-HLA and anti-AT1R antibodies after kidney transplantation

Samuele Iesari, Quirino Lai, Evaldo Favi, Francesco Pisani

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)679-681
Number of pages3
JournalYonsei Medical Journal
Volume58
Issue number3
DOIs
Publication statusPublished - May 1 2017

ASJC Scopus subject areas

  • Medicine(all)

Cite this